-
3-yloxy)
pyrimidin-
2-ylthio]acetohydrazide, N' -[
1-(4-hydroxyphenyl)ethylidene]-
2-[6-methyl-
4(thietan
NOOTROPIC ACTIVITY OF A NOVEL (-)-CYTISINE DERIVATIVE (3AR,4S,8S,12R, 12AS,12BR)-10-METHYL-2-PHENYLOCTAHYDRO-1H-4,12A-ETHENO-8,12-METHANOPYRROLO[3’,4’:3,4]PYRIDO[1,2-A] [1,5]DIAZOCINE-1,3,5(4H)-TRIONE Makara, N.S.,
Sapozhnikova, T.A.,
Khisamutdinova, R.Y.,
Tsypysheva, I.P.,
Borisevich, S.S.,
Kovalskaya, A.V.,
Petrova, P.R.,
Khursan, C.L.,
Zarudii, F.S. (2018) conditions (
3aR,
4S,8S,12R,12aS,12bR)-10-methyl-
2-phenyloctahydro-
1H-
4,12a-etheno-8,12-methanopyrrolo[
3’,4’:3,4Meshcheryakova, S.,
Shumadalova, A.,
Beylerli, O.,
Gareev, I.,
Zhao, S.,
Wu, J. (2022) properties. N
3-(thietan-
3-yl)- and N
3-(1,1-dioxothietan-
3-yl)uracils derivatives were synthesized
in pathological processes of type
2 diabetes. The aim of the study was to analyze TP53TG
1, LINC00342, MALAT
1,
H19
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022) , including
3-bromo-5-methoxy-
4-nitro-
1-(thietan-
3-yl)-
1H-pyrazole with antioxidant action and
2-{[3-bromo-
4Khaliullin, F.A.,
Klen, E.E.,
Nikitina, I.L.,
Pavlov, V.N.,
Rozit, G.A.,
Gaisina, G.G.,
Samorodov, A.V. (2023) Thietane-containing
4-(2-oxo-
2-phenylethyl)-
1H-
1,2,4-triazol-
4-ium bromides were synthesized
Khaliullin, F. A.,
Klen, E. E.,
Nikitina, I. L.,
Pavlov, V. N.,
Rozit, G. A.,
Gaisina, G. G.,
Samorodov, A. V. (2023) Thietane-containing
4-(2-oxo-
2-phenylethyl)-
1H-
1,2,4-triazol-
4-ium bromides were synthesized